Roivant Sciences Ltd. (ROIV) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Roivant Sciences Ltd. (ROIV) Earnings Overview
As of June 23, 2026, Roivant Sciences Ltd. (ROIV) reported trailing twelve-month net income of -$300M, reflecting -79.2% year-over-year growth. The company earned $-0.37 per diluted share over the past four quarters, with a net profit margin of -3629.2%.
Looking at the long-term picture, ROIV's historical earnings data spans multiple years. The company achieved its highest annual net income of $4.35B in fiscal 2023.
Roivant Sciences Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BHVN (-$648M net income), IMVT (-$506M net income), KYMR (-$315M net income, -794.4% margin), ROIV has comparable earnings metrics. Compare ROIV vs BHVN →
ROIV Earnings vs Peers
Earnings metrics vs comparable public companies
ROIV Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$300M | -74.3% | -$1.29B | $-0.43 | -3629.2% | -15560.6% |
| 2024 | -$172M | -104.0% | -$1.11B | $-0.24 | -592.0% | -3833.3% |
| 2023 | $4.35B | +531.0% | -$825M | $5.23 | 13294.2% | -2521.7% |
| 2022 | -$1.01B | -19.4% | -$809M | $-1.42 | -3200.2% | -2565.9% |
| 2021 | -$845M | -4.5% | -$1.21B | $-1.26 | -1528.9% | -2191.8% |
| 2020 | -$809M | -167.4% | -$1.07B | $-1.18 | -3400.9% | -4500.5% |
| 2019 | $1.20B | - | -$532M | $1.75 | 1773.6% | -786.6% |
Download Data
Export ROIV earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into ROIV consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ROIV — Frequently Asked Questions
Quick answers to the most common questions about buying ROIV stock.
What is ROIV earnings per share (EPS)?
ROIV trailing twelve-month (TTM) diluted EPS is $-0.37, reflecting -79.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Roivant Sciences Ltd.'s net income?
Roivant Sciences Ltd. (ROIV) trailing twelve-month net income is $-300M as of 2025. Earnings declined -79.2% year-over-year.
Is ROIV profitable?
ROIV is not currently profitable on a TTM basis, reporting a net loss of $-300M. Net margin is -3629.2%. Investors should monitor for a return to profitability.
What is ROIV's earnings growth rate?
ROIV compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are ROIV's profit margins?
Roivant Sciences Ltd. net profit margin is -3629.2%, operating margin is -15560.6%, and gross margin is +84.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is -5.7%.
Is ROIV growing earnings?
ROIV earnings are declining — EPS fell -79.2% year-over-year. TTM net income dropped to $-300M. This contrasts with the 5-year CAGR of N/A.
What was ROIV's best earnings year?
Roivant Sciences Ltd.'s highest annual net income on record is $4.3B, achieved in fiscal year 2023. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were ROIV's earnings last quarter?
ROIV's most recent reported quarter was Q4 2025. Net income was $303M with diluted EPS of $0.37. For a full breakdown of all quarters, see the quarterly earnings table on this page.